DSRLF (Diasorin SpA) Cyclically Adjusted Revenue per Share: $22.70 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DSRLF Diasorin SpA DSRLF
72 GF Score
Price $85.47
GF Value $96.51
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Diasorin SpA Cyclically Adjusted Revenue per Share?

Diasorin SpA DSRLF 72 Cyclically Adjusted Revenue per Share is $22.70 as of Jun. 2026. GuruFocus rates DSRLF with a GF Score™ of 72/100 and a GF Value™ of $96.51 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Diasorin SpA's adjusted revenue per share for the three months ended in Jun. 2026 was $6.486. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $22.70 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Diasorin SpA's average Cyclically Adjusted Revenue Growth Rate was 8.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 13.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Diasorin SpA was 16.60% per year. The lowest was 6.90% per year. And the median was 12.25% per year.

As of today (2026-08-16), Diasorin SpA's current stock price is $85.47. Diasorin SpA's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was $22.70. Diasorin SpA's Cyclically Adjusted PS Ratio of today is 3.77.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Diasorin SpA was 20.24. The lowest was 2.87. And the median was 8.83.


Diasorin SpA  (OTCPK:DSRLF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Diasorin SpA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=85.47/22.70
=3.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Diasorin SpA was 20.24. The lowest was 2.87. And the median was 8.83.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Diasorin SpA Cyclically Adjusted Revenue per Share Related Terms


Diasorin SpA Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Diasorin SpA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diasorin SpA Cyclically Adjusted Revenue per Share Chart

Diasorin SpA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.11 17.58 18.05 19.63 21.71

Diasorin SpA Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.66 24.25 21.71 22.55 22.70

DSRLF vs TMO, DHR, IDXX: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Diasorin SpA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diasorin SpA Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's Cyclically Adjusted PS Ratio falls into.


DSRLF
72GF Score
Diasorin SpA DSRLF
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diasorin SpA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Diasorin SpA's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=6.486/126.4000*126.4000
=6.486

Current CPI (Jun. 2026) = 126.4000.

Diasorin SpA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 3.013 100.100 3.805
201612 3.005 100.300 3.787
201703 3.076 101.000 3.850
201706 3.319 101.100 4.150
201709 3.252 101.200 4.062
201712 3.608 101.200 4.506
201803 3.661 101.800 4.546
201806 3.560 102.400 4.394
201809 3.473 102.600 4.279
201812 3.647 102.300 4.506
201903 3.531 102.800 4.342
201906 3.705 103.100 4.542
201909 3.518 102.900 4.321
201912 3.675 102.800 4.519
202003 3.521 102.900 4.325
202006 4.270 102.900 5.245
202009 4.901 102.300 6.056
202012 6.025 102.600 7.423
202103 5.798 103.700 7.067
202106 5.473 104.200 6.639
202109 7.377 104.900 8.889
202112 7.817 106.600 9.269
202203 7.198 110.400 8.241
202206 6.393 112.500 7.183
202209 6.014 114.200 6.656
202212 6.912 119.000 7.342
202303 5.802 118.800 6.173
202306 5.831 119.700 6.157
202309 5.407 120.300 5.681
202312 6.176 119.700 6.522
202403 5.886 120.200 6.190
202406 6.061 120.700 6.347
202409 5.974 121.200 6.230
202412 5.799 121.200 6.048
202503 6.279 122.500 6.479
202506 6.549 122.700 6.746
202509 6.201 123.100 6.367
202512 6.135 122.600 6.325
202603 6.592 124.560 6.689
202606 6.486 126.400 6.486

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $22.70 mean?
Diasorin SpA (DSRLF) has a Cyclically Adjusted Revenue per Share of $22.70 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Diasorin SpA and its competitors.
Is Diasorin SpA's Cyclically Adjusted Revenue per Share too high?
Diasorin SpA's current Cyclically Adjusted Revenue per Share is $22.70. Overall, Diasorin SpA has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Diasorin SpA's Cyclically Adjusted Revenue per Share compare to TMO and DHR?
Diasorin SpA's Cyclically Adjusted Revenue per Share of $22.70 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Diasorin SpA and its competitors. Diasorin SpA's current Cyclically Adjusted Revenue per Share is $22.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diasorin SpA stock overvalued right now?
Based on GuruFocus' analysis, Diasorin SpA (DSRLF) is currently considered Modestly Undervalued. The stock's GF Value™ is $96.51, compared to a current price of $85.47 — trading 11.4% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $22.70. Diasorin SpA's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Diasorin SpA (DSRLF), the current Cyclically Adjusted Revenue per Share is $22.70 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diasorin SpA (DSRLF) Overvalued in 2026?

Based on GuruFocus' analysis, Diasorin SpA stock appears to be undervalued. The current stock price of $85.47 is trading 11.4% below its estimated GF Value™ of $96.51. GuruFocus considers Diasorin SpA to be Modestly Undervalued.

Key valuation signals for DSRLF:

  • Cyclically Adjusted Revenue per Share: $22.70
  • GF Value™: $96.51 vs. price of $85.47 (11.4% below fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the DSRLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Diasorin SpA Business Description

Address Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Diasorin develops and manufactures a broad portfolio of in vitro diagnostics for detecting pathogens and sample contamination from the human body, as well as for use in industrial settings, such as food and water contamination testing. The company operates three segments: immunodiagnostics (69% of sales), molecular diagnostics (16%), and licensed technologies (14%). Diasorin was an important manufacturer of covid tests, which boosted its profits during the pandemic, but this segment's importance has decreased over the years, and in 2025, it accounted for only 1% of total sales.
72GF Score

Get the complete analysis for DSRLF

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$85.47
Price
$96.51
GF Value